Peter Kisaakye
ID:
|
Feasibility of Routine Screening for Sexual Violence Against Children in Humanitarian Contexts in Uganda
REFNo: SS2265ES
The goal of the study is to expand the access of children/adolescents experiencing sexual violence to comprehensive sexual violence services in refugee settings in Uganda. The study’s specific objective is to assess the feasibility of adapting and implementing a multi-faceted screening intervention to expand such access.
|
Uganda |
2024-01-24 22:46:56 |
2027-01-24 |
Social Science and Humanities |
Non-Clinical Trial |
Non-degree Award |
|
Robert Newton Edward
ID: UNCST-2023-R006537
|
Study of Genomic Integrity and Safety of Stem-Cell Gene Therapy in Cohorts in Africa.
REFNo: HS3660ES
The overall aim of this research is to establish safe and accessible gene therapies for sickle cell disease by comparing and contrasting cohorts in Africa to the data already obtained from the USA and UK thus establishing a more accurate authentic dataset.
We hypothesise that patients with SCD may have elevated somatic mutation rates as compared to healthy non-SCD individuals and that the mutational processes driving the acquisition of these genetic lesions are varied from individual to individual.
|
UK |
2024-01-24 22:45:26 |
2027-01-24 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
Harriet Ajilong
ID: UNCST-2022-R005889
|
Assessing Vitamin D serum levels in HIV-positive adolescents 10-19 years with depression in Northern Uganda
REFNo: HS3454ES
To determine the burden of depression in HIV-positive adolescents at Gulu RRH,To assess for serum Vitamin D levels in HIV Positive adolescents 10-19 years with depressive symptoms in Gulu Regional Referral Hospital Methods,
|
Uganda |
2024-01-24 22:30:43 |
2027-01-24 |
Medical and Health Sciences |
Clinical Trial |
Non-degree Award |
|
Mercy Kainobwisho Kyomugasho
ID:
|
AN ANALYSIS OF THE BARRIERS TO PROTECTION AND COMMERCIALIZATION OF TRADEMARK ASSETS BY SMES IN THE NON-ALCOHOLIC BEVERAGE MANUFACTURING S IN UGANDA.
REFNo: SS2153ES
specific objectives of the study are to;
i. To investigate the relationship between trademark protection, licensing, valuation, collaterisation and commercialisation by SMEs in the non- alcoholic beverages in the manufacturing sector.
ii. To identify the barriers to protection, licensing, valuation and collateralisation of trademarks by SMEs in the manufacturing sector.
iii. To examine the legal and institutional framework for protecting, licensing, valuation and collateralisation of trademarks in Uganda.
iv. To propose effective ways for enhancing the protection, licensing, valuation and collateralisation of trademarks by SMEs in the manufacturing sector in Uganda
|
Uganda |
2024-01-23 18:58:37 |
2027-01-23 |
Social Science and Humanities |
Non-Clinical Trial |
Degree Award |
|
Joseph Rujumba Rujumba
ID: UNCST-2022-R011160
|
Combining monthly dihydroartemisinin-piperaquine and azithromycin for the post-discharge management of children with severe anaemia in Malawi, Kenya, and Uganda: Post-Discharge Malaria Chemoprevention -PDMC-II (acceptability and feasibility sub-study)
REFNo: HS3669ES
2)Explore perspectives of health care providers and caregivers on the feasibility of implementing PDMC with DP + AZ in children diagnosed with severe anaemia in Malawi and Uganda and generate insights for successful integration and scalability of PDMC with DP+AZ in resource-limited settings.,1)To assess health care provider and caregiver acceptability of PDMC with DP + AZ in children with severe anaemia at Malawi, Kenya, and Uganda trial sites. ,To determine the acceptability and feasibility from the health provider and patient/guardian perspective of delivering or receiving dihydroartemisinin-piperaquine (DP) and azithromycin (AZ) for the post-discharge management of children with severe anaemia in Malawi, Kenya, and Uganda.,
|
Uganda |
2024-01-23 18:57:41 |
2027-01-23 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
| View |
|
Sort By: |
|
|
|
| |
|